Neurology

Accurately diagnosing Alzheimer’s disease (AD) may soon become more efficient, thanks to a novel biomarker assessment strategy leveraging cerebrospinal fluid (CSF) and PET imaging data, according to a 10-year study conducted at university memory clinics in Europe.

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.

Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).

Long-term cognitive and psychosocial challenges faced by individuals recovering from anti-NMDAR encephalitis, despite many regaining independence, have been highlighted in a recent study.

A new study in the UK Biobank suggests that high cardiorespiratory fitness (CRF) can significantly reduce dementia risk and delay its onset, even in individuals with a genetic predisposition to the condition.

Significant fluctuations in cholesterol levels, unrelated to changes in medication, may serve as an early indicator of increased dementia risk in older adults, according to a recent press release from American Heart Association Scientific Sessions 2024.

Resilience in adolescents with juvenile fibromyalgia (JFM) may significantly alleviate emotional symptoms, providing fresh insights for clinicians treating this complex chronic pain condition.

Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.